Ensol Biosciences Inc. Logo

Ensol Biosciences Inc.

Develops AI-discovered peptide drugs for cancer, osteoarthritis, and Alzheimer's disease.

140610 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
대전광역시 유성구 테크노10로 51(탑립동), 대전광역시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Ensol Biosciences Inc. is a clinical-stage biopharmaceutical company developing innovative drugs for diseases with high unmet medical needs. The company specializes in creating PPI (Protein-Protein Interaction)-regulating short peptide drugs, utilizing a proprietary bio big data and AI platform for discovery and development. Its therapeutic approach focuses on local, non-blood injections to maximize efficacy, ensure high target specificity, and minimize systemic side effects due to a short half-life in the bloodstream. Ensol's clinical pipeline targets conditions such as osteoarthritis, degenerative disc disease, cancer, and Alzheimer's disease. Key candidates include E1K for osteoarthritis (preparing for Phase 3) and C1K, a combination cancer therapy (Phase 1).

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Ensol Biosciences Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Ensol Biosciences Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Ensol Biosciences Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
NANO MRNA Co.,Ltd. Logo
Biotech IP generator developing and licensing mRNA therapeutics using proprietary delivery systems.
Japan 4571
NATURECELL CO.,LTD. Logo
Biotech company developing stem cell therapies, food, beverages, and cosmetics.
South Korea 007390
A marketing support firm using a vast consumer panel for data-driven research and PR campaigns.
Japan 4196
Neovacs Logo
Develops immunotherapy vaccines for autoimmune diseases & invests in BioTech/MedTech companies.
France ALNEV
Mineral explorer of rare earths, niobium, uranium, and copper assets in Australia and Zambia.
Australia N/A
NFL Biosciences Logo
Develops botanical drug candidates to treat smoking and alcohol addictions.
France ALNFL
NGS Group Logo
Nordic staffing & recruitment for healthcare, education, and social services sectors.
Sweden NGS
Nihon M&A Center Holdings Inc. Logo
M&A advisory firm specializing in brokerage and consulting for Japanese SMEs, including cross-border deals.
Japan 2127
Noile-Immune Biotech Inc. Logo
Developing PRIME technology-enhanced CAR-T cell immunotherapies for treating solid tumors.
Japan 4893
NRGene Technologies Ltd. Logo
AI-powered genomic analysis software to accelerate and optimize plant and animal breeding.
Israel NRGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.